cefaclor anhydrous has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, WR; Hanasono, GK; Hoffman, DG; Morton, DM; Owen, NV | 1 |
| Bach, R; Federspil, P; Schätzle, W; Tiesler, E; Weich, C; Wilhelm, HJ | 1 |
2 other study(ies) available for cefaclor anhydrous and Thrombopenia
| Article | Year |
|---|---|
An evaluation of the toxicity of cefaclor in laboratory animals.
Topics: Animals; Body Weight; Cefaclor; Cephalexin; Diarrhea; Dogs; Drug Evaluation, Preclinical; Female; Haplorhini; Hemoglobins; Lethal Dose 50; Macaca mulatta; Male; Mice; Rats; Thrombocytopenia | 1979 |
[Experience with cefaclor in the treatment of ear, nose and throat infections. Indications for cefaclor therapy (author's transl)].
Topics: Adolescent; Adult; Aged; Cefaclor; Cephalexin; Female; Humans; Male; Middle Aged; Nausea; Otorhinolaryngologic Diseases; Staphylococcal Infections; Streptococcal Infections; Thrombocytopenia; Time Factors | 1979 |